Seeking Alpha

Johnson & Johnson's (JNJ -1.6%) slips today on a downgrade to Neutral at JPMorgan, saying...

Johnson & Johnson's (JNJ -1.6%) slips today on a downgrade to Neutral at JPMorgan, saying the stock has reached a "trading premium." Last June, JP notes, the stock was trading at a 5% discount to the "sum-of-its-parts." Now, after a 30% run, the shares trade at an 8% premium, and despite an improvement in the fundamentals, the stock is poised to plateau, at least over the near term. The firm did however, ratchet-up its price target to $83 from $77.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|